New generation implantable cardiac rhythm devices allow safe radiotherapy treatments: A large single centre study
Journal Title: Current Research: Cardiology - Year 2018, Vol 5, Issue 2
Abstract
INTRODUCTION: Many patients requiring radiotherapy for malignancies have an already implanted cardiac rhythm device. Previous studies reported a variety of device dysfunctions related to high dose radiation. Aim of this study was to assess the impact of current optimal radiotherapy treatment guided by computed tomography on current generation implantable devices. METHODS: Consecutive patients with implanted pacemakers (PMK) and implantable cardioverter defibrillators (ICD) referred for radiotherapy treatment in any district were enrolled at our Centre and followed prospectively with device interrogation before and just after each radiotherapy cycle. A magnet was positioned on the device in patients with implanted defibrillators or pacemaker-dependency. RESULTS: Overall, 48 patients (74.8 years (9.3), 39 males (81.3)) with implantable devices underwent radiotherapy (29 pacemakers and 19 ICDs). Interval between device implant and start of radiation therapy was 2.9 (1.6) years. Radiotherapy was performed under computed tomography guidance, and a mean of 73.5 (45.0) Gy were administered with a mean of 24.8 (14.6) fractionated doses. About half of the patients underwent thoracic radiotherapy, and 9 were treated for a left thoracic malignancy ipsilateral to the implanted device. No device failures were observed at post-treatment device interrogation, nor changes in electrical parameters, inappropriate shocks, device reprogramming or memory reset. None of the patients experienced premature battery failure or other unexpected anomalous findings at the end of the radiation therapy cycle. CONCLUSION: Radiation therapy for malignancies is safe among patients with implanted current generation cardiac rhythm devices.
Authors and Affiliations
Simone Gulletta, Mario Matta, Italo Dall’Oca, Giuseppe D’Angelo, Lorenzo Gigli, Andrea Radinovic, Manuela Cireddu, Alessandra Marzi, Nadia Di Muzio, Paolo Della Bella, Pasquale Vergara
Keywords
Related Articles
- EP ID EP603120
- DOI -
- Views 47
- Downloads 0
In hospital outcomes of primary percutaneous intervention in patients presenting with acute myocardial infarction in Saudi Arabia – A single center study
OBJECTIVE: To study the presentation, response to treatment, complication and prognosis of patients with acute ST-Elevation myocardial infarction (STEMI) who were treated with primary percutaneous coronary intervention (...
Pericardial lipoma: Diagnosed unexpectedly during heart failure investigation- Case Report
OBJECTIVE: To report the case of a patient with pericardial lipoma diagnosed unexpectedly during heart failure investigation with diagnosis definitive after surgery. METHODS: A review of medical records and analysis of...
Three-dimensional echocardiography of tricuspid valve for visualizing all the three leaflets
Three-dimensional echocardiography offers a unique opportunity of visualizing all the three leaflets of tricuspid valve in en-face view from transthoracic windows.It is very useful in localizing the position of the pacin...
Glycosylated hemoglobin and adverse events following elective coronary bypass revascularization
BACKGROUND: The aim of this retrospective study was to evaluate whether the level of preoperative glycosylated hemoglobin (HbA1c) is associated with incidence of major adverse events in patients undergoing elective coron...
Endovascular reconstruction of primary coarctation in a 12-year-old boy technical consideration
Coarctation is a generalized disease which mainly manifests in aorta and presents as aortic coarctation. While transcatheter approaches have replaced surgery, there is still no consensus about the best among only balloon...